Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
C

Protocol

More milk, yogurt and cheese for older adults in care homes

In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years.

Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

In a large study of 56 care homes in Australia, half the homes gave residents extra milk, yogurt and cheese each day. Over two years, those residents had a third fewer broken bones and about half as many broken hips. They fell a little less. Deaths did not change. Only one trial has shown this so far.

The letter, taken apart
What was measured
Fractures and falls over two years.
How big
All fractures were 33% lower (121 against 203) with added dairy foods.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 34670754.
Who it applies to
Older adults living in care homes.
Safety
No harms reported; serum lipids not worsened in a follow-up analysis.
The record in one view
Compared with
Usual care-home menus.
Certainty
Grade C, resting on: One large cluster randomized trial with fracture outcomes.
What would change this grade
Could rise to B with: Cluster randomized trial of dairy foods. Who: Care-home residents outside Australia. Measured: Fractures. Length: At least 2 years.
Cost
No price recorded yet.
Sources
1 study cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
Food
CHard clinical endpoint Grade C

In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years. Deaths did not change.

Why this letter

Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Why this grade

Grade C on fractures. A cluster randomized trial in 56 care homes found fewer fractures, including hip fractures, when dairy foods raised calcium and protein intake to recommended levels (Iuliano et al., 2021; PMID 34670754).

WHY NOT Bunder Rule 06 a single positive trial without independent replication The same finding reproduced by a separate research group. A result seen once can be chance or bias; a replicated one is harder to explain away. is a C; later papers from the same trial do not count as replication.

WHAT THIS GRADE DOES NOT COVERpeople living at home, calcium tablets, and dairy for heart disease or other outcomes. It also does not cover dairy added for people who already eat enough calcium and protein, since the trial raised intake only up to recommended levels.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: randomized trial

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Fractures (hard)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignCluster randomized trial of dairy foods
PopulationCare-home residents outside Australia
EndpointFractures
DurationAt least 2 years

A positive trial of this shape, supported by further trials, would move this entry to B.

Why the current trials fall short

An independent replication would carry it to B.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Dairy Products among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Dairy Products on ClinicalTrials.gov

Dose, form and timing

What to track

Not applicable; the outcome is fractures.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 464 · November 2026 · First graded.
Grade history
No. 464 · November 2026 · First graded
More milk, yogurt and cheese for older adults in care homes is added from the gap report: Grade C

New record in the gap-report batch. In a cluster trial across 56 Australian care homes, adding milk, yogurt and cheese to bring calcium and protein intake up to recommended levels cut fractures by 33%, hip fractures by 46% and falls by 11% over two years. Deaths did not change.PMID 34670754

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullOne paper, linked to its PubMed record.
The evidence

Iuliano et al. (BMJ, 2021; PMID 34670754): cluster randomized trial, 27 intervention and 29 control care homes in Australia, 7,195 residents, mean age about 86; all fractures 121 against 203 (HR 0.67, 95% CI 0.48 to 0.93), hip fractures 42 against 93 (HR 0.54), falls 1,879 against 2,423 (HR 0.89); mortality unchanged.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 8 records screened, 1 eligible for the graded claim.
Query: (dairy[tiab] OR milk[tiab]) AND fracture*[tiab] AND randomized controlled trial[pt]
The 8 most recent of 31 records were screened by title; the 2023 and 2024 papers report the same trial (PMID 34670754), not a replication.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the search behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Who paid for these trials

For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.

  • Iuliano et al., 2021, BMJ (PMID 34670754): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026